Moxibustion on Shenque(CV 8) Improves Effect of Acupuncture for Diarrhea-predominant Irritable Bowel Syndrome

被引:0
|
作者
Liu Xiao-xia [1 ]
Han Chou-ping [1 ]
机构
[1] Acupuncture Department of Kunshan Bacheng People’s Hospital
关键词
Acupuncture Therapy; Acupuncture-moxibustion Therapy; Indirect Moxibustion; Diarrhea; Irritable Bowel Syndrome;
D O I
暂无
中图分类号
R246.1 [内科];
学科分类号
100512 ;
摘要
Objective: To observe the clinical effect of acupuncture and moxibustion on diarrhea-predominant irritable bowel syndrome(IBS-D). Methods: A total of 60 IBS-D patients were randomly allocated into a treatment group and a control group, 30 in each group. Patients in the treatment group were treated with acupuncture combined with ginger and salt-partitioned moxibustion on Shenque(CV 8), whereas patients in the control group only received acupuncture treatment. Six days made up a course of treatment, and the clinical effects were statistically analyzed after 4 courses. Results: The overall response rate in the treatment group was 96.7%, versus 76.7% in the control group, showing a statistical significance(P<0.05). In the intra-group comparison of the symptom scores after treatment, there were statistical differences in both groups(both P<0.01), and in the inter-group comparison, the difference was statistically significant(P<0.05). Conclusion: Acupuncture combined with ginger and salt-partitioned moxibustion on Shenque(CV 8) can obtain better effect for ISB-D than acupuncture alone.
引用
收藏
页码:362 / 365
页数:4
相关论文
共 50 条
  • [31] Metabolomics analysis of herb-partitioned moxibustion treatment on rats with diarrhea-predominant irritable bowel syndrome
    Xianwei Lin
    Xia Liu
    Jingjing Xu
    Kian-Kai Cheng
    Jianan Cao
    Tao Liu
    Qiong Liu
    Huan Zhong
    Guiping Shen
    Jiyang Dong
    Xiaorong Chang
    Chinese Medicine, 14
  • [32] The Fecal Microbiome in Children With Diarrhea-Predominant Irritable Bowel Syndrome
    Michail, Sonia
    Kenche, Harshavadran
    GASTROENTEROLOGY, 2010, 138 (05) : S14 - S14
  • [33] Advancements in drug development for diarrhea-predominant irritable bowel syndrome
    Dothel, Giovanni
    Barbaro, Maria Raffaella
    Raschi, Emanuel
    Barbara, Giovanni
    De Ponti, Fabrizio
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (03) : 251 - 263
  • [34] Diagnostic Yield of Testing in Diarrhea-predominant Irritable Bowel Syndrome
    Manolakis, Catherine
    Di Palma, Jack
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S490 - S490
  • [35] Rifaximin in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome
    Dai, Cong
    Jiang, Min
    Sun, Ming-Jun
    GASTROENTEROLOGY, 2017, 152 (06) : 1629 - +
  • [36] Acupuncture for Adults with Diarrhea-Predominant Irritable Bowel Syndrome or Functional Diarrhea: A Systematic Review and Meta-Analysis
    Guo, Jianbo
    Xing, Xiaoxiao
    Wu, Jiani
    Zhang, Hui
    Yun, Yongen
    Qin, Zongshi
    He, Qingyong
    NEURAL PLASTICITY, 2020, 2020
  • [37] Targeting diarrhea-predominant irritable bowel syndrome: hopes or hypes?
    Bassotti, Gabrio
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2024,
  • [38] Decreased mucosal cytokines in diarrhea-predominant irritable bowel syndrome
    Chang, L
    Anton, P
    Elliott, J
    Reinholdt, J
    Taing, P
    Mayer, E
    GASTROENTEROLOGY, 2002, 122 (04) : A552 - A552
  • [39] RIFAXIMIN IS A SAFE THERAPY FOR DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME
    Weinstock, Leonard B.
    Pimentel, Mark
    Heimanson, Zeev
    Lembo, Anthony
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 : S331 - S332
  • [40] Misinterpreting Diarrhea-Predominant Irritable Bowel Syndrome and Functional Diarrhea: Pathophysiological Highlights
    Sciume, Giusi Desire
    Berti, Ginevra
    Lambiase, Christian
    Paglianiti, Italia
    Villanacci, Vincenzo
    Rettura, Francesco
    Grosso, Antonio
    Ricchiuti, Angelo
    Bortoli, Nicola de
    Usai Satta, Paolo
    Bassotti, Gabrio
    Bellini, Massimo
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (18)